Waikato Hospital, Te Whatu Ora Health New Zealand Waikato
Hamilton, New Zealand
NCT Number: NCT07115420
This study looks at the best way to treat bile duct blockage in people with advanced cancer that cannot be removed by surgery. A blocked bile duct can cause serious symptoms like yellowing of the skin (jaundice), infection, and pain.
A common procedure called ERCP sometimes doesn't work in these patients. A newer method called EUS-guided choledochoduodenostomy (EUS-CDS) uses internal ultrasound to place a special metal tube (called a LAMS) to allow bile to drain. However, over time this stent can still become blocked.
To reduce this risk, doctors can place a second stent inside the first. This study is comparing two types of these second stents:
* A plastic stent (double pigtail stent or DPS) * A metal stent (fully covered self-expanding metal stent or FCSEMS)
The study will include patients at Waikato Hospital. After the first stent is placed, they will be randomly assigned to receive either a DPS or FCSEMS. Patients will be followed for 6 months to see how well the stents work.
The aim is to find out which approach keeps the bile duct open longer and reduces the need for further procedures or hospitalisation, helping improve care and comfort for people with advanced cancer
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Hamilton, New Zealand
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In those randomised to FCSEMS, size will depend on the size of the LAMS with a 6mm LAMS to be stented with 8mm diameter FCSEMS and an 8mm LAMS to be stented with a 10mm FCSEMS, 4cm or 6cm length. The aim is to have at least 3cm of FCSEMS in the duodenal lumen If unable to place FCSEM through LAMS, crossover to DPS is allowed with plan for both intention to treat and per protocol analysis to be undertaken after completion of the study
In those randomised to DPS, a double pigtail will be placed through the LAMS. The size of the stents will be left to the discretion of the proceduralist though 7Fr calibre with 7cm length is the recommended size
Time frame: 26 weeks
Time frame: 1 day
Whether the LAMS stent is able to be successfully placed in the procedure
Time frame: 1 day
Whether the second stent (either FCSEMS or DPS) is able to be placed successfully
Time frame: weeks 1, 2, 4, 12, and 26
whether biliary drainage has been successful based on biochemical blood tests
Time frame: 26 weeks
blockage of the LAMS stent requiring repeat procedure(s) as evidenced by clinical, biochemical evidence, and/or radiological evidence of biliary obstruction
Trial opening soon.
Get NotifiedWaikato Hospital
Other
Optimising EUS-guided Choledochoduodenostomy With Lumen Apposing Metal Stent With Stent in Stent Placement: a Randomised Study Between Double Pigtail Stent and Fully Covered Self-Expanding Metal Stent. The Opti-LAMS Study
Acronym: Opti-LAMS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07558304
Adenocarcinoma, Bile Duct Diseases
Porto Alegre, Rio Grande do Sul, Brazil
View Trial DetailsNCT07811791
Biliary Drainage, Biliary Tract Diseases
Hsinchu, Taiwan
View Trial DetailsNCT07606430
Digestive System Diseases, Digestive System Neoplasms
View Trial DetailsNCT06550973
Malignant Biliary Obstruction
View Trial Details